Subramanian D, Cruz CV, Garcia-Bournissen F. Systematic review of early phase pediatric clinical pharmacology trials. J Pediatr Pharmacol Ther. 2022;27:609–17.

PubMed  PubMed Central  Google Scholar 

Joseph PD, Craig JC, Caldwell PHY. Clinical trials in children. Br J Clin Pharmacol. 2015;79:357–69.

Article  PubMed  PubMed Central  Google Scholar 

Schupmann W, Li X, Wendler D. Acceptable risks in pediatric research: views of the US public. Pediatrics. 2021;149:1–10.

Google Scholar 

Burckart GJ, Kim C. The revolution in pediatric drug development and drug use: therapeutic orphans no more. J Pediatr Pharmacol Ther. 2020;25:565–73.

PubMed  PubMed Central  Google Scholar 

Bourgeois FT, Kesselheim AS. Promoting pediatric drug research and labeling: outcomes of legislation. N Engl J Med. 2022;381(9):875–81.

Article  Google Scholar 

Baum VC, Bax R, Heon D, Yang Z, Sakiyama M. Pediatric drug regulation: international perspectives. Paediatr Anaesth. 2019;29:572–82.

Article  PubMed  Google Scholar 

Moore-Hepburn C, Rieder M. Paediatric pharmacotherapy and drug regulation: moving past the therapeutic orphan. Br J Clin Pharmacol. 2022;88:4250–7.

Article  PubMed  Google Scholar 

Sharif R, Aamir M, Shakeel F, Faisal S, Khan JA. Pharmacoepidemiological assessment of off-label drug use in pediatric ambulatory departments at four tertiary care hospitals in Pakistan. Trop J Pharm Res. 2020;19:2219–25.

Article  CAS  Google Scholar 

Allen HC, Garbe MC, Lees J, Aziz N, Miller JL, Johnson P, et al. Off-label medication use in children, more common than we think: a systematic review of the literature. J Okla State Med Assoc. 2019;111:776–83.

Google Scholar 

Hoon D, Taylor MT, Kapadia P, Gerhard T, Strom BL, Horton DB. Trends in off-label drug use in ambulatory settings: 2006–2015. Pediatrics. 2019;144:1–19.

Article  Google Scholar 

Tukayo BLA, Sunderland B, Parsons R, Czarniak P. High prevalence of off-label and unlicensed paediatric prescribing in a hospital in Indonesia during the period Aug–Oct 2014. PLoS ONE. 2020;15:1–13.

Article  Google Scholar 

Yackey K, Stukus K, Cohen D, Kline D, Zhao S, Stanley R. Off-label medication prescribing patterns in pediatrics: an update. Hosp Pediatr. 2019;9:186–93.

Article  PubMed  Google Scholar 

Hwang TJ, Orenstein L, Kesselheim AS, Bourgeois FT. Completion rate and reporting of mandatory pediatric postmarketing studies under the US Pediatric Research Equity Act. JAMA Pediatr. 2019;173:68–74.

Article  PubMed  Google Scholar 

Srivastava A, Bourgeois FT. Evaluation of publication of pediatric drug trials. JAMA Netw Open. 2021;4:14–7.

Article  Google Scholar 

van den Anker J, Reed MD, Allegaert K, Kearns GL. Developmental changes in pharmacokinetics and pharmacodynamics. J Clin Pharmacol. 2018;58:S10-25.

PubMed  Google Scholar 

Smits A, Annaert P, Cavallaro G, De Cock PAJG, de Wildt SN, Kindblom JM, et al. Current knowledge, challenges and innovations in developmental pharmacology: a combined conect4children Expert Group and European Society for Developmental, Perinatal and Paediatric Pharmacology White Paper. Br J Clin Pharmacol. 2022;88:4965–84.

Article  PubMed  Google Scholar 

Van Groen BD, Nicolaï J, Kuik AC, Van Cruchten S, Van Peer E, Smits A, et al. Ontogeny of hepatic transporters and drug-metabolizing enzymes in humans and in nonclinical species. Pharmacol Rev. 2021;73:597–678.

Article  PubMed  Google Scholar 

Lu H, Rosenbaum S. Developmental pharmacokinetics in pediatric populations. J Pediatr Pharmacol Ther. 2014;19:262–76.

PubMed  PubMed Central  Google Scholar 

Nicolas JM, Bouzom F, Hugues C, Ungell AL. Oral drug absorption in pediatrics: the intestinal wall, its developmental changes and current tools for predictions. Biopharm Drug Dispos. 2017;38:209–30.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wanat K. Biological barriers, and the influence of protein binding on the passage of drugs across them. Mol Biol Rep. 2020;47:3221–31.

Article  CAS  PubMed  Google Scholar 

Alavijeh MS, Chishty M, Qaiser MZ, Palmer AM. Drug metabolism and pharmacokinetics, the blood-brain barrier, and central nervous system drug discovery. NeuroRx. 2005;2(4):554–71. https://doi.org/10.1602/neurorx.2.4.554.

Debotton N, Dahan A. A mechanistic approach to understanding oral drug absorption in pediatrics: an overview of fundamentals. Drug Discov Today. 2014;19:1322–36.

Article  CAS  PubMed  Google Scholar 

Batchelor HK, Marriott JF. Paediatric pharmacokinetics: key considerations. Br J Clin Pharmacol. 2015;79:395–404.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bansal N, Momin S, Bansal R, Gurram Venkata SKR, Ruser L, Yusuf K. Pharmacokinetics of drugs: newborn perspective. Pediatr Med. 2024;7:19.

Kiss M, Mbasu R, Nicolaï J, Barnouin K, Kotian A, Mooij MG, et al. Ontogeny of small intestinal drug transporters and metabolizing enzymes based on targeted quantitative proteomics. Drug Metab Dispos. 2021;49:1038–46.

Article  CAS  PubMed  Google Scholar 

Baptista JP. Augmented renal clearance. In: Antibiotic pharmacokinetic/pharmacodynamic considerations in the critically ill. Editors: Udy A, Roberts J, Lipman J. Adis, Singapore. https://doi.org/10.1007/978-981-10-5336-8_7

Quigley R. Developmental changes in renal function. Curr Opin Pediatr. 2012;24:184–90.

Article  PubMed  Google Scholar 

Gattineni J, Baum M. Developmental changes in renal tubular transport: an overview. Pediatr Nephrol. 2015;30:2085–98.

Article  PubMed  Google Scholar 

Mulla H. Understanding developmental pharmacodynamics: importance for drug development and clinical practice. Pediatr Drugs. 2010;12:223–33.

Article  Google Scholar 

Ross RK, Kinlaw AC, Herzog MM, Funk MJ, Gerber JS. Fluoroquinolone antibiotics and tendon injury in adolescents. Pediatrics. 2021;147: e2020033316.

Article  PubMed  Google Scholar 

Pacifici GM. Clinical Pharmacology of Digoxin in Infants and Children. Clin Med. 2021;3(2):1036.

Moon YE. Paradoxical reaction to midazolam in children. Korean J Anesthesiol. 2013;65:2–3.

Article  PubMed  PubMed Central  Google Scholar 

Liu XI, Schuette P, Burckart GJ, Green DJ, La J, Burnham JM, et al. A comparison of pediatric and adult safety studies for antipsychotic and antidepressant drugs submitted to the United States Food and Drug Administration. J Pediatr. 2019;208:236-242.e3.

Article  PubMed  PubMed Central  Google Scholar 

Plebani M. Errors in clinical laboratories or errors in laboratory medicine? Clin Chem Lab Med. 2006;44:750–9.

Article  CAS  PubMed  Google Scholar 

Himebauch AS, Sankar WN, Flynn JM, Sisko MT, Moorthy GS, Gerber JS, et al. Skeletal muscle and plasma concentrations of cefazolin during complex paediatric spinal surgery. Br J Anaesth. 2016;117:87–94.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dalmage MR, Nwankwo A, Sur H, Nduom E, Jackson S. A scoping review of pediatric microdialysis: a missed opportunity for microdialysis in the pediatric neuro-oncology setting. Neurooncol Adv. 2022;4:1–8.

Google Scholar 

Ketharanathan N, Yamamoto Y, Rohlwink UK, Wildschut ED, Mathôt RAA, De Lange ECM, et al. Combining brain microdialysis and translational pharmacokinetic modeling to predict drug concentrations in pediatric severe traumatic brain injury: the next step toward evidence-based pharmacotherapy? J Neurotrauma. 2019;36:111–7.

Article  PubMed  Google Scholar 

Dilo A, Daali Y, Desmeules J, Chalandon Y, Uppugunduri CRS, Ansari M. Comparing dried blood spots and plasma concentrations for busulfan therapeutic drug monitoring in children. Ther Drug Monit. 2020;42:111–7.

Article  CAS  PubMed  Google Scholar 

Klak A, Pauwels S, Vermeersch P. Preanalytical considerations in therapeutic drug monitoring of immunosuppressants with dried blood spots. Diagnosis. 2019;6:57–68.

Article  PubMed  Google Scholar 

Doriety LJ, Farrington EA. Urine drug screening: what pediatric clinicians need to know to optimize patient care. J Pediatr Health Care. 2021;35:449–55.

Article  PubMed  Google Scholar 

Hutchinson L, Sinclair M, Reid B, Burnett K, Callan B. A descriptive systematic review of salivary therapeutic drug monitoring in neonates and infants. Br J Clin Pharmacol. 2018;84:1089–108.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kuwayama K, Miyaguchi H, Iwata YT, Kanamori T, Tsujikawa K, Yamamuro T, et al. Time-course measurements of drug concentrations in hair and toenails after single administrations of pharmaceutical products. Drug Test Anal. 2017;9:571–7.

Article  CAS  PubMed  Google Scholar 

Sabir AM, Moloy M, Bhasin PS. Hplc method development and validation: a review. Int Res J Pharm. 2016;4:39–46.

Article  Google Scholar 

Decosterd LA, Widmer N, André P, Aouri M, Buclin T. The emerging role of multiplex tandem mass spectrometry analysis for therapeutic drug monitoring and personalized medicine. TrAC. 2016;84:5–13.

CAS  Google Scholar 

Dasgupta A. Limitations of immunoassays used for therapeutic drug monitoring of immunosuppressants. In: Personalized immunosuppression in transplantation role of biomarker monitoring and therapeutic drug monitoring. Editors: Oellerich M, Dasgupta A. Amsterdam: Elsevier Inc.;2016.

Google Scholar 

Aucella F, Lauriola V, Vecchione G, Tiscia GL, Grandone E. Liquid chromatography-tandem mass spectrometry method as the golden standard for therapeutic drug monitoring in renal transplant. J Pharm Biomed Anal. 2013;86:123–6.

Article  CAS